SEC Tracker
Get the app

Senti Biosciences SNTI

Senti Biosciences (SNTI) announced the resignation of its Chief Executive Officer, effective immediately. This unexpected leadership change introduces uncertainty and potential disruption to the company's strategic direction and operations, which could impact shareholder value.

Form
8-K
Filed
Importance
Major

Open in the appGet the appView on EDGAR

Get an email when Senti Biosciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Avalo Therapeutics AVTX public float $54M, Jun 30, 2025
  2. Cue Biopharma CUE public float $52M, Jun 30, 2025
  3. Fitlife Brands FTLF public float $51M, Jun 30, 2025
  4. Immucell ICCC public float $51M, Jun 30, 2025
  5. iBio IBIO public float $58M, Dec 31, 2025